Zetagen Therapeutics is a clinical-stage biopharmaceutical company that develops cancer treatments for metastatic bone cancers and osteologic interventions. It offers a synthetic small molecule designed to suspend cancer, inhibit pain, and regenerate bone and for ancillary osteologic treatments.